PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade
Hironori Yoshida, Takashi Nomizo, Hiroaki Ozasa, Takahiro Tsuji, Tomoko Funazo, Yuto Yasuda, Hitomi Ajimizu, Masatoshi Yamazoe, Kiyomitsu Kuninaga, Tatsuya Ogimoto, Kazutaka Hosoya, Ryo Itotani, Yuichi Sakamori, Young Hak Kim, Toyohiro Hirai
Topics & Concepts
BlockadeOncologyLung cancerMedicineInternal medicinePD-L1CancerImmunotherapyReceptorCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesLung Cancer Research Studies